PT FONKO INTERNATIONAL PHARMACEUTICALS

About PT FONKO INTERNATIONAL PHARMACEUTICALS

Fonko Pharma was founded in 2010 to manufacture high-quality oncology products (injectable and oral solid products) worldwide. Its high-tech production facilities and state-of-the-art global regulatory compliance enable Fonko to produce oncology drugs with active ingredients (APIs) up to OEB 5 (most toxic levels).Fonko facility already EU GMP certified. Fonko provides contract manufactur...

Certifications
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
  • Kawasan Industri Jababeka II, Jl. Industri Selatan V Blok PP No 7, Cikarang, 17856, Bekasi, Indonesia

Products from PT FONKO INTERNATIONAL PHARMACEUTICALS (3)

  • Bendamustine 25, 100

    Product Bendamustine 25, 100

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bendamustine 25 mg and 100 mg. Indication : Chronic lymphocytic Leukemia, Non-Hodgin Lymphoma and Multiple Myeloma. Contact us for more information.
  • Bortezomib 1, 3.5

    Product Bortezomib 1, 3.5

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bortezomib 1 mg, 3.5 mg Indication : multiple myeloma, mantle cell lymphoma. Contact us for more information.
  • Paclitaxel 30, 100, 300

    Product Paclitaxel 30, 100, 300

    PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Paclitaxel 30 mg, 100 mg and 300 mg. Indication : Ovarian carcinoma, Breast carcinoma, Advanced non-small cell lung carcinoma, AIDS-related Kaposi's sarcoma. Contact us for more information